Get the tools used by (smart)2 investors.

Revenue CAGR (5y) for Johnson & Johnson

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

JNJ: Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, In...

163.63 USD
Price
USD
Fair Value
Upside
140.68 - 169.99
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Johnson & Johnson's Revenue CAGR (5y):

JNJHLTH.USBMYMRKLLYNVSTLPH-20.0%-10.0%0.0%10.0%

Performance Summary
  • Johnson & Johnson's revenue cagr (5y) is 1.6%

Benchmarks

Metric Usage: Revenue CAGR (5y)

Hide this widget
total_rev_cagr_5y
Slug
number
Datatype
text
Format
current
Default Period
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Revenue CAGR (5y) in the growth category include:

View Full List

Search for metric or datapoint

Revenue CAGR (5y)

Five-year compound annual growth rate in revenue.

Definition of Revenue CAGR (5y)

Hide this widget

Revenue CAGR (5y) measures the five-year compound annual growth rate in Revenue.

Compound annual growth rate (CAGR) is a commonly used business and investing term that measures the growth of a metric over multiple periods. CAGRs are useful since they reduce the effect of volatility in specific periods, unlike arithmetic means.

You can find the calculation details for Johnson & Johnson’s Revenue CAGR outlined below. The calculation starts by listing values for Revenue for the last six fiscal years that are required to calculate CAGR:

Johnson & Johnson's Revenue History
Fiscal YearRevenueYoY Growth
2019-12-29T00:00:00.000Z82.059 B
2021-01-03T00:00:00.000Z82.584 B0.6%
2022-01-02T00:00:00.000Z78.74 B−4.7%
2023-01-01T00:00:00.000Z79.99 B1.6%
2023-12-31T00:00:00.000Z85.159 B6.5%
2024-12-29T00:00:00.000Z88.821 B4.3%

Using the values for Revenue listed in the table above, we can calculate three-year Revenue CAGR as follows:

 Number of years  =  5
 Multiplier       =  $88.821 B / $82.059 B  =  1.08
 5 Year CAGR     =  1.08 ^ (1/5) - 1  =  1.6%

Growth calculations are always made in the company’s reporting currency to ensure currency fluctuations do not impact the calculation. Johnson & Johnson’s reports in the USD currency. You can read more about Revenue here and compound annual growth rate on Wikipedia. You may also find variants three-year Revenue CAGR, and seven-year Revenue CAGR useful.


Click the link below to download a spreadsheet with an example Revenue CAGR (5y) calculation for Johnson & Johnson below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-43.9%11.1%66.1%170.1%50150250

The chart above depicts the distribution of revenue cagr (5y) for companies operating in the Healthcare sector in the Developed economic region. Over 1,530 companies were considered in this analysis, and 1,473 had meaningful values. The average revenue cagr (5y) of companies in the sector is 15.9% with a standard deviation of 29.4%.

Johnson & Johnson's Revenue CAGR (5y) of 1.6% ranks in the 24.8% percentile for the sector. The following table provides additional summary stats:

Revenue CAGR (5y) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents1,535
Included Constituents1,473
Min-44.6%
Max166.3%
Median9.4%
Mean15.9%
Standard Deviation29.4%

You can find companies with similar revenue cagr (5y) using this stock screener.

All rights reserved. Terms Of Use